ProteKt Therapeutics raised €3.3M in a funding round in Oct 2019. The company is based in Ness Ziona, Israel. Investors in the round: Bukwang Pharmaceutical Co, Fonds de solidarité FTQ. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.
